Quent Capital, LLC

Position in VTRS — Viatris Inc

CIK 1912338 NEW YORK, NY

Position in VTRS

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$43,623

+$1,368 QoQ

Shares Held

3,229

-4.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Quent Capital, LLC holds $2,626,931 across 11 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	4,123	$2,444,856
2	ZTS	Zoetis Inc.	436	$51,539
3	VTRS	Viatris Inc This page	3,229	$43,623
4	NBIX	Neurocrine Biosciences Inc	188	$24,767
5	ALKS	Alkermes plc.	678	$23,974
6	HIMS	Hims & Hers Health, Inc.	491	$10,193
7	INCR	Intercure Ltd.	10,321	$7,751
8	ELAN	Elanco Animal Health Inc	299	$7,155

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$43,623	3,229	-4.9%	Shares	Sole	2026-04-28
2025-12-31	$42,255	3,394	+6.4%	Shares	Sole	2026-01-29
2025-09-30	$31,571	3,189	+117.7%	Shares	Sole	2025-10-27
2025-03-31	$12,760	1,465	-8.8%	Shares	Sole	2025-04-04
2024-12-31	$20,007	1,607	+1.3%	Shares	Sole	2025-01-29
2024-09-30	$18,425	1,587	+19.4%	Shares	Sole	2024-10-04
2024-06-30	$14,127	1,329	-4.7%	Shares	Sole	2024-07-08
2024-03-31	$16,644	1,394	+5.5%	Shares	Sole	2024-06-28
2023-12-31	$14,306	1,321	-1.5%	Shares	Sole	2024-06-17
2023-09-30	$13,222	1,341	-63.8%	Shares	Sole	2024-06-17
2023-06-30	$36,945	3,702	-13.0%	Shares	Sole	2024-06-17
2023-03-31	$40,952	4,257	+2.6%	Shares	Sole	2024-06-17
2022-12-31	$46,189	4,150	+12.7%	Shares	Sole	2023-01-19
2022-09-30	$31,379	3,683	+173.6%	Shares	Sole	2022-11-10
2022-06-30	$14,092	1,346	-36.4%	Shares	Sole	2022-08-08
2022-03-31	$23,043	2,118	+45.1%	Shares	Sole	2022-05-12
2021-12-31	$19,753	1,460	—	Shares	Sole	2022-05-12
No filing history on record for this holder in this stock.